Oxford Nanopore Technologies /£ONT
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Oxford Nanopore Technologies
Oxford Nanopore Technologies plc, trading under the ticker ONT, operates in the biotechnology sector, focusing on the development of nanopore technology for DNA and RNA sequencing. Founded in 2005 and publicly listed, the company's innovative technology facilitates real-time, scalable, and accessible biological research, with applications ranging from healthcare to environmental science. Based in the UK, Oxford Nanopore has revolutionized the approach to molecular analysis by providing a direct and electric characterization of single molecules.
Ticker
£ONT
Sector
Primary listing
LSE
Employees
1,325
Headquarters
Website
ONT Metrics
BasicAdvanced
£1.6B
-
-£0.15
0.85
-
Price and volume
Market cap
£1.6B
Beta
0.85
52-week high
£2.25
52-week low
£0.89
Average daily volume
1.8M
Financial strength
Current ratio
4.789
Quick ratio
3.892
Long term debt to equity
7.318
Total debt to equity
8.426
Interest coverage (TTM)
-50.23%
Profitability
EBITDA (TTM)
-134.528
Gross margin (TTM)
57.30%
Net profit margin (TTM)
-70.00%
Operating margin (TTM)
-72.76%
Effective tax rate (TTM)
-4.16%
Revenue per employee (TTM)
£150,000
Management effectiveness
Return on assets (TTM)
-13.35%
Return on equity (TTM)
-26.01%
Valuation
Price to revenue (TTM)
7.533
Price to book
2.98
Price to tangible book (TTM)
3.31
Price to free cash flow (TTM)
-10.32
Free cash flow yield (TTM)
-9.69%
Free cash flow per share (TTM)
-0.158
Growth
Revenue change (TTM)
22.01%
Earnings per share change (TTM)
-18.95%
3-year revenue growth (CAGR)
1.27%
3-year earnings per share growth (CAGR)
-7.90%
What the Analysts think about ONT
Analyst ratings (Buy, Hold, Sell) for Oxford Nanopore Technologies stock.
Bulls say / Bears say
The company expects fiscal‐year 2025 revenue of approximately £183 million, up 8% from 2023, driven by expansion into applied industrial, biopharma, and clinical sectors, underscoring successful diversification beyond research markets (Reuters).
Oxford Nanopore reaffirmed its medium‐term financial targets, including achieving adjusted EBITDA break‐even by 2027 and positive cash flow by 2028, providing a clear roadmap to profitability (Reuters).
Major investors such as Larry Ellison and Novo Holdings have maintained or increased their stakes, reflecting strong institutional confidence in the company’s long‐term prospects despite market volatility (Financial Times).
The share price has plunged about 85% from its 2021 peak, highlighting significant investor disappointment and potential valuation concerns (Financial Times).
The firm faces material uncertainty, with 10–15% of revenues tied to U.S. federal funding via the NIH and export control tightening further threatening revenue growth in 2025 (Reuters).
A £6 million charge for a 5% workforce reduction in early 2025 underscores ongoing cost pressures, which may hamper operational scalability and innovation efforts (Reuters).
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.
ONT Financial Performance
Revenues and expenses
ONT Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Oxford Nanopore Technologies stock?
Oxford Nanopore Technologies (ONT) has a market cap of £1.6B as of September 18, 2025.
What is the P/E ratio for Oxford Nanopore Technologies stock?
The price to earnings (P/E) ratio for Oxford Nanopore Technologies (ONT) stock is 0 as of September 18, 2025.
Does Oxford Nanopore Technologies stock pay dividends?
No, Oxford Nanopore Technologies (ONT) stock does not pay dividends to its shareholders as of September 18, 2025.
When is the next Oxford Nanopore Technologies dividend payment date?
Oxford Nanopore Technologies (ONT) stock does not pay dividends to its shareholders.
What is the beta indicator for Oxford Nanopore Technologies ?
Oxford Nanopore Technologies (ONT) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.